ConductScience.org, home

Paper64803

Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.

Marshall AJ and 3 others. Lancet, 1977. Cited by 56 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. Papers, record 64803. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/64803

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
PubMed
Journal
Lancet
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
3.57
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marshall AJA J
2Barritt DWD W
3Pocock JJ
4Heaton STS T

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BendroflumethiazideMajor topic
HypertensionMajor topic
PrazosinMajor topic
QuinazolinesMajor topic
Adult
Aged
Atenolol
Blood Pressure
Clinical Trials as Topic
Drug Evaluation
Drug Synergism
Drug Therapy, Combination
Female
Heart Rate
Humans
Male
Middle Aged
Oxprenolol
Propranolol

Source PubMed

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
30,221,227Phosphatase CDC25B Inhibitors Produced by Basic Alumina-Supported One-Pot Gram-Scale Synthesis of Fluorinated 2-Alkylthio-4-aminoquinazolines Using Microwave Irradiation.ACS Omega2018https://conductscience.org/library/papers/30221227PubMed
7,437,237Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7437237PubMed
7,388,366Hypokalaemia and diuretics: an analysis of publications.Br Med J1980https://conductscience.org/library/papers/7388366PubMed
7,295,482Assessment of natriuretic drugs.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7295482PubMed
7,093,116Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093116PubMed
7,066,169The addition of prazosin to standard triple therapy in the treatment of severe hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7066169PubMed
6,992,462Antihypertensive pharmacology.West J Med1980https://conductscience.org/library/papers/6992462PubMed
6,487,502Xipamide: no advantage over bendrofluazide in hypertension.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487502PubMed
6,357,257Hydralazine and prazosin in the treatment of hypertension.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6357257PubMed
6,122,737What should we do about mild hypertension?J R Coll Physicians Lond1982https://conductscience.org/library/papers/6122737PubMed
6,122,463Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6122463PubMed
6,109,022Diuretic and beta-blocker in hypertension--then what?J R Coll Physicians Lond1980https://conductscience.org/library/papers/6109022PubMed
3,899,671A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3899671PubMed
702,462Altitude sickness.J R Coll Gen Pract1978https://conductscience.org/library/papers/702462PubMed
630,494Prazosin hydrochloride.Can Med Assoc J1978https://conductscience.org/library/papers/630494PubMed
143,363Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.Drugs1977https://conductscience.org/library/papers/143363PubMed
38,096Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.Drugs1979https://conductscience.org/library/papers/38096PubMed
26,370The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26370PubMed
23,284Antihypertensive drugs: clinical pharmacology and therapeutic use.Drugs1977https://conductscience.org/library/papers/23284PubMed
20,118Treating hypertension. The place of beta blockade.Br Heart J1977https://conductscience.org/library/papers/20118PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/64803

GET https://conductscience.org/api/papers/v1/64803/authors